Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Nippon Shinyaku patents

Patents where

Current Assignee

Name

Nippon Shinyaku

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7612205 Crystals of quinolinecarboxylic acid derivative solvate	Patent 7612205 was granted and assigned to Nippon Shinyaku on November, 2009 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	7612205	November 3, 2009
‌ US Patent 11382912 Controlled-release preparation		Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	11382912	July 12, 2022
‌ US Patent 11377453 Crystal of compound having JAK-inhibiting activity	Patent 11377453 was granted and assigned to Nippon Shinyaku on July, 2022 by the United States Patent and Trademark Office.	Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	11377453	July 5, 2022
‌ US Patent 7494997 Amide derivative	Patent 7494997 was granted and assigned to Nippon Shinyaku on February, 2009 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	7494997	February 24, 2009
‌ US Patent 8673891 Aminopyrazine derivative and medicine	Patent 8673891 was granted and assigned to Nippon Shinyaku on March, 2014 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	8673891	March 18, 2014
‌ US Patent 7820629 Galactose derivative, drug carrier and medicinal composition	Patent 7820629 was granted and assigned to Nippon Shinyaku on October, 2010 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	7820629	October 26, 2010
‌ US Patent RE46364 Fibrosis inhibitor	Patent RE46364 was granted and assigned to Nippon Shinyaku on April, 2017 by the United States Patent and Trademark Office.	Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	RE46364	April 11, 2017
‌ US Patent 7728131 Amide derivative and medicine	Patent 7728131 was granted and assigned to Nippon Shinyaku on June, 2010 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	7728131	June 1, 2010
‌ US Patent 11560401 Method for preparing oligonucleic acid compound		Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	11560401	January 24, 2023
‌ US Patent 8729086 Fibrosis inhibitor	Patent 8729086 was granted and assigned to Nippon Shinyaku on May, 2014 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	8729086	May 20, 2014
‌ US Patent 9440931 Form-III crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and use thereof	Patent 9440931 was granted and assigned to Nippon Shinyaku on September, 2016 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	9440931	September 13, 2016
‌ US Patent 7718663 Quinazoline derivatives and medicaments	Patent 7718663 was granted and assigned to Nippon Shinyaku on May, 2010 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	7718663	May 18, 2010
‌ US Patent 10822350 Crystal of compound having JAK-inhibiting activity	Patent 10822350 was granted and assigned to Nippon Shinyaku on November, 2020 by the United States Patent and Trademark Office.	Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	10822350	November 3, 2020
‌ US Patent 9937176 Pyrazolothiazole compound and medicine comprising same	Patent 9937176 was granted and assigned to Nippon Shinyaku on April, 2018 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	9937176	April 10, 2018
‌ US Patent 7884116 Octahydronaphthalene derivative and medicine	Patent 7884116 was granted and assigned to Nippon Shinyaku on February, 2011 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	7884116	February 8, 2011
‌ US Patent 8889693 Fibrosis inhibitor	Patent 8889693 was granted and assigned to Nippon Shinyaku on November, 2014 by the United States Patent and Trademark Office.	Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	8889693	November 18, 2014
‌ US Patent 8969551 Morpholino nucleic acid derivatives	Patent 8969551 was granted and assigned to Nippon Shinyaku on March, 2015 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	8969551	March 3, 2015
‌ US Patent 9284280 Use of form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide	Patent 9284280 was granted and assigned to Nippon Shinyaku on March, 2016 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	9284280	March 15, 2016
‌ US Patent 9999622 Pyrazolothiazole compound and medicine comprising same	Patent 9999622 was granted and assigned to Nippon Shinyaku on June, 2018 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	9999622	June 19, 2018
‌ US Patent 8158774 Method for introducing a nucleic-acid protecting group	Patent 8158774 was granted and assigned to Nippon Shinyaku on April, 2012 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	8158774	April 17, 2012
‌ US Patent 8791122 Form-I crystal of 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsulfonyl)acetamide and method for producing the same	Patent 8791122 was granted and assigned to Nippon Shinyaku on July, 2014 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	8791122	July 29, 2014
‌ US Patent 8835446 Quinazoline derivatives and pharmaceutical compositions thereof	Patent 8835446 was granted and assigned to Nippon Shinyaku on September, 2014 by the United States Patent and Trademark Office.	Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	8835446	September 16, 2014
‌ US Patent 10906879 Crystalline substituted pyrazines as PGI2 receptor agonists	Patent 10906879 was granted and assigned to Nippon Shinyaku on February, 2021 by the United States Patent and Trademark Office.	Nippon Shinyaku	Nippon Shinyaku	United States Patent and Trademark Office	10906879	February 2, 2021
‌ US Patent 8691970 Phosphoramidite compound and method for producing oligo-RNA	Patent 8691970 was granted and assigned to Nippon Shinyaku on April, 2014 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	8691970	April 8, 2014
‌ US Patent 9216968 Heterocyclic derivative and pharmaceutical drug	Patent 9216968 was granted and assigned to Nippon Shinyaku on December, 2015 by the United States Patent and Trademark Office.		Nippon Shinyaku	United States Patent and Trademark Office	9216968	December 22, 2015

Results per page:

43 results

0 selected

43 results

0 selected